News & Events

The COVIRNA project was presented at the Back to a Healthy Future event 

On 21 - 22 September, the Back to a Healthy Future event took place in Brussels. This technological showcase event brought together companies and organisations from many European countries willing to respond rapidly to urgent needs in the healthcare system. The particular focus was on solutions t...

Read More
EHMA 2022 session hosted by COVIRNA

Event report: COVIRNA session at the EHMA 2022 Annual Conference highlights the potential of innovative diagnostic tools

On Friday, 17 June, the COVIRNA project hosted a session at the EHMA 2022 Annual Conference titled ‘The potential of innovative diagnostic tools: personalised disease management for improved health outcomes in COVID-19 patients’. The session looked at the impact and benefits of the adoption of no...

Read More
COVIRNA project at the EHMA 2022 Annual Conference

COVIRNA project to host a session at the EHMA 2022 Annual Conference

The COVIRNA project will be participating in the EHMA 2022 Annual Conference with the session ‘The potential of innovative diagnostic tools: personalised disease management for improved health outcomes in COVID-19 patients’, on Friday, 17 June at 11:15 AM CET. EHMA 2022 Annual Conference&nbs...

Read More
COVIRNA project featured at European events on cardiovascular medicine

COVIRNA project featured at the European events on cardiovascular medicine

In April, the COVIRNA project was featured at three European events focused on cardiovascular medicine. Dr Yvan Devaux, the COVIRNA Project Coordinator, represented the project at the final EU-CARDIOPROTECTION COST Action meeting on 2-4 April in Coimbra (Portugal), 2nd Olympiad in Cardiovascular ...

Read More
lncRNA Biomarker of cardiovascular disease

lncRNA: Biomarker for diagnosing and prognosing cardiovascular diseases

Cardiovascular diseases (CVDs) are the leading cause of death globally. According to the World Health Organisation, an estimated 17.9 million people die each year from CVDs. This represents 32% of all global deaths. CVDs are responsible for twice as many death as cancer in both men and women.&nbs...

Read More
Interview with Dr Kanita Karaduzovic-Hadziabdic

COVIRNA project: Watch the interview with Dr Kanita Karađuzović-Hadžiabdić

Although lungs are the main organs involved in COVID-19, one of the major systems affected by the virus is the cardiovascular system. The presence of preexisting cardiovascular disease increases mortality in patients with COVID-19, and cardiovascular injuries are observed in some patients with CO...

Read More
First COVIRNA Annual Meeting

The First COVIRNA Annual Meeting takes place in Barcelona

The First Annual Meeting of the COVIRNA project took place on 11-12 November 2021 in Barcelona, Spain. The meeting was co-organised by the Luxembourg Institute of Health (LIH), the project coordinator and the Institute of Research of Hospital de la Santa Creu i Sant Pau (IR-HSCSP). It brought tog...

Read More

COVIRNA project: Early detection for improved cardiovascular health outcomes of the European population

In the spring of 2020, most European citizens, although fearful of the virus the global media was reporting on, could not possibly envisage that their lives would be so dramatically impacted and that the economic, social and environmental impacts of the COVID-19 pandemic would be so tangible. Acc...

Read More

The COVIRNA Project Coordinator, Dr Yvan Devaux, discusses the project on Radio ARA

On Thursday, 7 October 2021, from 18:30 to 20:00 CEST, Dr Yvan Devaux, the COVIRNA project coordinator, was a guest speaker at Happy Hour, a show hosted by Wendy Winn on Radio ARA. Dr Devaux spoke about the COVIRNA project and cardiovascular disease management.  Dr Devaux started by providin...

Read More
Key learnings from the COVIRNA session at the EHMA 2021 Annual Conference

COVIRNA session at the EHMA 2021 Annual Conference highlights the role of predictive models in improving patient outcomes

On Wednesday, 15 September from 13:30-14:45 CEST, the COVIRNA project hosted a session at the EHMA 2021 Annual Conference titled Towards personalised medicine – an innovative diagnostic tool to identify cardiovascular complications in COVID-19 patients. The session examined the benefits of person...

Read More